ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update

Go back to ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
(NASDAQ: ABVC) Delayed: 0.93 -0.03 (3.13%)
Previous Close $0.96    52 Week High $25.00 
Open $0.97    52 Week Low $1.00 
Day High $0.98    P/E N/A 
Day Low $0.89    EPS $0.00 
Volume 73,772